{"id":"b766fa5c-d202-4275-85aa-d6d40d76d734","name":"Noah Medical","slug":"noah-medical","description":"Robotic lung navigation platform company. $200M total raised. Series B ($150M). Acquired. Product: robotic bronchoscopy navigation system for lung biopsy and diagnostics.","status":"private","founded":0,"hq":"USA","hqLat":39.7837304,"hqLng":-100.445882,"hqGeocodedAt":"2026-08-05T14:41:12.605Z","hqAddress":null,"hqPrecision":null,"website":"noahmed.com","fundingTotal":"600000000","type":"hardware","roles":[],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://growthlist.co/robotics-startups/","title":"GrowthList","sourceName":"GrowthList","dateAccessed":"2022026-07-22"},{"url":"https://www.noahmed.com/press-releases/noah-medical-raises-150m-series-b-to-scale-endoluminal-robotics-solutions","date":"2023-04-19","title":"Noah Medical Raises $150M Series B to Scale Endoluminal Robotics Solutions","sourceName":"Noah Medical"},{"url":"https://noahmedical.com/","title":"Noah Homepage","sourceName":"Noah Medical"}],"keyFacts":[{"label":"Total Funding","value":"$200M (Series B $150M)"},{"label":"Product","value":"Robotic lung navigation/bronchoscopy"},{"label":"Status","value":"Acquired"},{"label":"Series B Galaxy System (primary Noah Medical)","value":"Noah Medical's Apr 19 2023 press release says it raised $150 million Series B led by Softbank Vision Fund and co-led by Prosperity7 Ventures, with Tiger Global and existing investors including Hillhouse, Sequoia China, Shangbay Capital, Uphonest Capital, Sunmed Capital, Lyfe Capital, 1955 Capital, and AME Cloud Ventures. Funds are described as meeting demand for the Galaxy System navigated robotic bronchoscopy platform ([Noah Medical](https://www.noahmed.com/press-releases/noah-medical-raises-150m-series-b-to-scale-endoluminal-robotics-solutions))","sourceUrl":"https://www.noahmed.com/press-releases/noah-medical-raises-150m-series-b-to-scale-endoluminal-robotics-solutions"},{"label":"Galaxy TiLT+ and FDA note (primary Noah Medical)","value":"The same release says Galaxy System uses proprietary TiLT+ Technology with integrated tomosynthesis and augmented fluoroscopy, a single-use disposable bronchoscope, and a compact footprint. It states the platform received FDA clearance for commercial use in the United States and that first-in-human trials had started at Macquarie University Hospital in Sydney. Treat device claims as company-stated ([Noah Medical](https://www.noahmed.com/press-releases/noah-medical-raises-150m-series-b-to-scale-endoluminal-robotics-solutions))","sourceUrl":"https://www.noahmed.com/press-releases/noah-medical-raises-150m-series-b-to-scale-endoluminal-robotics-solutions"},{"label":"Galaxy robotic bronchoscopy system","value":"Noah Medical presents the Galaxy System as a robotic bronchoscopy platform for reaching and sampling peripheral lung nodules ([Noah Medical](https://noahmedical.com/)).","sourceUrl":"https://noahmedical.com/"},{"label":"Integrated imaging tools","value":"Noah Medical describes Galaxy as combining tool-in-lesion imaging, digital tomosynthesis, and augmented fluoroscopy to support bronchoscopic procedures ([Noah Medical](https://noahmedical.com/)).","sourceUrl":"https://noahmedical.com/"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-22T21:32:37.672Z","updatedAt":"2026-09-29T22:30:21.175Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/noah-medical","url":"https://registry.deploy.report/companies/noah-medical","name":"Noah Medical","description":"Robotic lung navigation platform company. $200M total raised. Series B ($150M). Acquired. Product: robotic bronchoscopy navigation system for lung biopsy and diagnostics.","identifier":"b766fa5c-d202-4275-85aa-d6d40d76d734","address":"USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}